Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by newdaydawningon Feb 25, 2019 5:53pm

171 Views

Post# 29411461

Shirazi and Lade should alleviate financing concerns

The combined experience and contacts of our two new CEOs will definitely help TLT in future money raises. Indeed, bolstering the balance sheet should be a top priority for Shirazi in particular.

Powered by ever-more positive news in the coming months, TLT and its new executives may well be able to pull off a financing at all-time highs. Fingers crossed!

Bullboard Posts

A Look into the Future of Chronic Pain Management